These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 22577236

  • 1. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L, Becker G, Vacher B, Billard T, Lancelot S, Newman-Tancredi A, Zimmer L.
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [Abstract] [Full Text] [Related]

  • 2. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L, Verdurand M, Vacher B, Blanc E, Le Bars D, Newman-Tancredi A, Zimmer L.
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [Abstract] [Full Text] [Related]

  • 3. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C, Mawatari A, Kawasaki A, Takeda C, Onoe K, Doi H, Newman-Tancredi A, Zimmer L, Onoe H.
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
    Lemoine L, Andries J, Le Bars D, Billard T, Zimmer L.
    J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
    [Abstract] [Full Text] [Related]

  • 5. 18F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT1A receptor agonist for PET neuroimaging.
    Vidal B, Fieux S, Colom M, Billard T, Bouillot C, Barret O, Constantinescu C, Tamagnan G, Newman-Tancredi A, Zimmer L.
    Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
    [Abstract] [Full Text] [Related]

  • 6. Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT.
    Jagoda EM, Lang L, Tokugawa J, Simmons A, Ma Y, Contoreggi C, Kiesewetter D, Eckelman WC.
    Synapse; 2006 May; 59(6):330-41. PubMed ID: 16440292
    [Abstract] [Full Text] [Related]

  • 7. Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat.
    Assié MB, Lomenech H, Ravailhe V, Faucillon V, Newman-Tancredi A.
    Br J Pharmacol; 2006 Sep; 149(2):170-8. PubMed ID: 16921393
    [Abstract] [Full Text] [Related]

  • 8. A comparison of in vivo and in vitro neuroimaging of 5-HT 1A receptor binding sites in the cat brain.
    Aznavour N, Rbah L, Léger L, Buda C, Sastre JP, Imhof A, Charnay Y, Zimmer L.
    J Chem Neuroanat; 2006 Apr; 31(3):226-32. PubMed ID: 16517120
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA, Mu L, Honer M, Belli S, Alf MF, Schubiger PA, Krämer SD, Ametamey SM.
    Neuroimage; 2011 Jun 01; 56(3):984-91. PubMed ID: 21406237
    [Abstract] [Full Text] [Related]

  • 10. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.
    Vidal B, Sebti J, Verdurand M, Fieux S, Billard T, Streichenberger N, Troakes C, Newman-Tancredi A, Zimmer L.
    Neuropharmacology; 2016 Oct 01; 109():88-95. PubMed ID: 27183968
    [Abstract] [Full Text] [Related]

  • 11. Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study.
    Buritova J, Berrichon G, Cathala C, Colpaert F, Cussac D.
    Neuropharmacology; 2009 Feb 01; 56(2):350-61. PubMed ID: 18809418
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.
    Kumar JS, Majo VJ, Hsiung SC, Millak MS, Liu KP, Tamir H, Prabhakaran J, Simpson NR, Van Heertum RL, Mann JJ, Parsey RV.
    J Med Chem; 2006 Jan 12; 49(1):125-34. PubMed ID: 16392798
    [Abstract] [Full Text] [Related]

  • 13. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA, McCormick P, Kapur S, Willeit M, Garcia A, Hussey D, Houle S, Seeman P, Ginovart N.
    J Med Chem; 2005 Jun 16; 48(12):4153-60. PubMed ID: 15943487
    [Abstract] [Full Text] [Related]

  • 14. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A.
    Neuropharmacology; 2015 Jun 16; 93():52-67. PubMed ID: 25645393
    [Abstract] [Full Text] [Related]

  • 15. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.
    Bioconjug Chem; 2008 Dec 16; 19(12):2462-70. PubMed ID: 19053298
    [Abstract] [Full Text] [Related]

  • 16. Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.
    Cosi C, Waget A, Rollet K, Tesori V, Newman-Tancredi A.
    Brain Res; 2005 May 10; 1043(1-2):32-41. PubMed ID: 15862515
    [Abstract] [Full Text] [Related]

  • 17. Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18.
    Hamill TG, Sato N, Jitsuoka M, Tokita S, Sanabria S, Eng W, Ryan C, Krause S, Takenaga N, Patel S, Zeng Z, Williams D, Sur C, Hargreaves R, Burns HD.
    Synapse; 2009 Dec 10; 63(12):1122-32. PubMed ID: 19670309
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
    Chen YY, Wang X, Zhang JM, Deuther-Conrad W, Zhang XJ, Huang Y, Li Y, Ye JJ, Cui MC, Steinbach J, Brust P, Liu BL, Jia HM.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5270-8. PubMed ID: 25189691
    [Abstract] [Full Text] [Related]

  • 19. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.
    Newman-Tancredi A, Martel JC, Assié MB, Buritova J, Lauressergues E, Cosi C, Heusler P, Bruins Slot L, Colpaert FC, Vacher B, Cussac D.
    Br J Pharmacol; 2009 Jan 01; 156(2):338-53. PubMed ID: 19154445
    [Abstract] [Full Text] [Related]

  • 20. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N, Seeman P, Garcia A, Stableford WT, Nobrega JN, Houle S, Wilson AA.
    Nucl Med Biol; 2007 Feb 01; 34(2):195-203. PubMed ID: 17307127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.